Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile (Monitor- ACS)

Fundación EPIC

Status

Completed

Conditions

Syncope

Atrial Fibrillation

Tachycardia

Arrhythmias, Cardiac

Heart Diseases

Treatments

Device: Biomonitor-2 and Kardia mobile

Other: No Intervention

Study type

Interventional

Funder types

Other

Identifiers

Monitor- ACS - EPIC 013

Details and patient eligibility

About

The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.

Full description

The objective of the study is to evaluate the efficacy of monitoring after discharge of patients with high-risk acute coronary syndrome.

Enrollment

169 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient is able to understand the nature of study and has provided written informed consent.
Patient with Acute Coronary Syndrome, with or without elevation of the ST segment at the EKG (the last with elevation of troponins).
Patient with coronariography at the episode of ACS showing severe lesions treated with stent.
Patient with risk index for 6-month mortality (GRACE score) of more than 118.
Patient with risk index for stroke (CHA2DS2-VACS score) of more than 2.

Exclusion criteria

Patient with history of AF.
Patient with episodes of AF during admission at the current episode.
Patient with pacemaker or ICD (implantable cardioverter-defibrillator) previously.
Patient with indication of pacemaker or ICD in current or short-term phase.
Patient is participating in another interventional clinical investigation.
Patient is pregnant or breast feeding.
Patient´s life-expectancy is less than 24 months.